Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.
The digital therapeutics market is expected to witness a CAGR of 32.1% during the forecast period of 2025 to 2033, driven by the increasing burden of chronic diseases, the imperative to curb rising healthcare costs and ongoing technological advancements. However, regulatory challenges pose a notable restraint, necessitating collaborative efforts for streamlined validation processes. Market segmentation reveals distinct trends in application focus, end-use preferences, and sales channel dynamics.
Diabetes is a prolonged, enduring disease characterized by high blood glucose level arising when the pancreas are no longer capable to secrete insulin: a key hormone that processes glucose to produce energy. Inability to produce insulin or use it effectively leads to the raised glucose level in the blood (hyperglycemia). Over long term, high blood glucose level can damage the blood vessels in the heart, kidneys, eyes or the nervous system.
Biometrics in healthcare applications essentially refer to staff and patient identification solutions. Biometrics solutions are often used in combination with smart cards and passwords for secure access to sensitive records and reports, and to facilitate patient registration requirements. In the near future biometrics use in healthcare will reflect the growing demand to address healthcare frauds in the developed markets along with the escalating need to ensure patient privacy.
Cracked heels, also known as heel fissure are usually caused by xerosis (dry skin). Rising number of obese population, increasing incidence of diseases such as diabetes and thyroid, rising consumer awareness and easy availability of cost effective products are the key growth drivers of global cracked heels treatment market.
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. Polycystic ovarian syndrome (PCOS) therapeutics market is rapidly growing due to factors such as growing prevalence, changing lifestyle pattern, early diagnosis and significant unmet needs.
The anti-snoring devices and snoring surgery market is expected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2033. The market addresses a prevalent and disruptive issue affecting a significant portion of the population. The anti-snoring devices and snoring surgery market are driven by increasing awareness, technological advancements, and the rising prevalence of snoring-related disorders. However, the market faces challenges related to user discomfort and compliance issues.
Collagen Peptide and Gelatin Market by Raw Material (Pig Skin, Bovine Hides, Cattle Bones and Others) by Application (Food and Beverages, Nutraceuticals, Pharmaceuticals, Personal Care and Others) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025
Urinary tract infection (UTI) is a most common type of infection, it involve infection to the kidneys, ureters, bladder, or urethra. UTI treatment market is rapidly growing due to factors such as growing prevalence of UTI, significant unmet needs, rising number of drug resistant bacteria due to excessive use of antibiotics.
The drivers responsible for the market penetration of high throughput process development are the rising prevalence of chronic diseases and burgeoning requirement to shorten the time required for the biological drug candidates’ clinical trials and commercialization. Strong limitations of high throughput process development are the lack of adequate infrastructure, technical challenges and stringent regulatory guidelines will hamper the market growth of high throughput process development.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.